Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
about
Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells.Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathwayMeta-analysis of the effects of oral and intravenous dexamethasone premedication in the prevention of paclitaxel-induced allergic reactions.Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells.Microtubule-based force generation.Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivoUnmonitored use of herbal medicine by patients with breast cancer: reframing expectations.Specialized Plant Metabolism Characteristics and Impact on Target Molecule Biotechnological Production.Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application.miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.A hindsight reflection on the clinical studies of poly(l-glutamic acid)-paclitaxel.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells.Redox Paradox: A novel approach to therapeutics-resistant cancer.Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.In vitro and in vivo cytotoxic effect of AntiGan against tumor cells.Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.Proinflammatory Factors Mediate Paclitaxel-Induced Impairment of Learning and Memory.Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
P2860
Q33634260-03EE75DE-1AA1-4C8F-899A-49A9C877F570Q37652873-2878415A-EE58-4FCB-9A8B-AD70C96540FFQ37687176-6998AFEC-B8CE-45FB-B3D6-820565836FA5Q37687329-2C32B341-1C04-4F8B-ADCF-BE3D21228278Q37745970-5726FF2A-F84B-4094-ACD9-DA3753A370B3Q38599086-84161497-E341-4143-A329-A68A472458B4Q38721352-93E0FFD8-B8F5-4E62-8418-E3FD12393B8AQ38796544-7719434C-6A1D-42C5-AEDC-F0440C8D7D7AQ38937416-5202DFBF-DA52-46BC-BDFD-022CC5528724Q38949920-C5FE89A4-E21E-4641-95F6-C482D278413BQ39153420-4BD21694-C7A4-4277-A71D-ABC7A1B546A0Q47229394-C6A8806A-69DF-405C-A243-5980A80711A9Q47729970-F92EEF80-88B2-4E4B-9E07-6252C3544758Q47756168-CD1AB550-3ADE-4895-93B7-9BF47E22C3D4Q47988571-24652AEE-69A8-4BAF-9714-2B5CFC036B44Q48087890-B3806E32-0ABA-4FB6-A01B-FBD50E8E1BB8Q49387560-86A718D0-3834-45F1-91AA-5A69698D6C06Q49747089-762041EF-D630-493A-8106-E6542AA9AAC8Q50082485-0FABE400-AD04-46D5-97D2-7AC2BEBB6C0DQ50113702-96539B8B-C960-4F52-90C8-1BEDF3E1953EQ50287987-843AE9FD-9667-41C6-A41A-A9170558EEF2Q52679106-8301128F-D563-43E0-8CEB-C74D14437436Q52800940-D95DBF77-EC07-4C5F-AD44-552F23689B2EQ53467366-7C673933-7C4B-4D9C-AEBA-58C8BECFCCACQ55054276-CBF06594-D281-4A8E-BC97-51EC6A025A87Q55085143-5B5E8AA8-E883-4E99-B71B-86007C45D9B4Q55121508-9F9C0088-EA0E-42B7-B8C1-5B47AB303406Q58793764-9625F39E-E00C-4450-9815-6AA27E21C567
P2860
Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@ast
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@en
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@nl
type
label
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@ast
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@en
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@nl
prefLabel
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@ast
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@en
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@nl
P2860
P356
P1433
P1476
Paclitaxel Through the Ages of ...... sistance and Radiation Therapy
@en
P2093
Anna Maria Barbuti
P2860
P304
P356
10.3390/CANCERS7040897
P407
P577
2015-01-01T00:00:00Z